Paul Offit warned that launching a two-dose version of the vaccine down the road might cause problems. "You can see where that would be confusing to people thinking, ’Maybe I didn’t get what I needed,’" said Offit, a vaccine expert at Children’s Hospital of Philadelphia. "...
Johnson & Johnson's single-dose vaccine protects againstCOVID-19, according to an analysis by U.S. regulators Wednesday. The analysis sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic. The Food and Drug Administration's scientistsconfirmedthat ove...
Benefits include that it only requires one dose — as opposed to Moderna and Pfizer'stwo-dose inoculations— and that it can be stored in a regular refrigerator. "There's no question that this vaccine is going to be a game-changer," Dr. Mathai Mammen, global head of pharmaceutical researc...
Global control of COVID-19 requires broadly accessible vaccines that are effective against SARS-CoV-2 variants. In this report, we exploit the immunostimulatory properties of bacille Calmette-Gu茅rin (BCG), the existing tuberculosis vaccine, to deliver a vaccination regimen with potent SARS-CoV-2-...
Johnson & Johnson and the FDA on Wednesday released respective detailed analysis on the one-shot COVID-19 vaccine, with the FDA announcing the company's data meets the requirements for the emergency use authorization review process. FDA scientists found that the Johnson & Johnson vaccine w...
BERLIN, May 24 (Xinhua) -- The German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute (RKI) on Tuesday extended its general COVID-19 vaccination recommendation to children between the ages of 5 and 11 with only one vaccine dose. ...
The Miami Heraldreports on Johnson & Johnson’s single-dose COVID-19 vaccine, writing: The U.S. Food and Drug Administration released a report on Wednesday that says the one-dose Johnson & Johnson COVID-19 vaccine has a “favorable safety profile with no specific safety concerns,” clearing...
The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has voted to recommend Johnson & Johnson's COVID-19 vaccine for emergency use for individuals ages 18 and older in the United States.
JOHNSON & JOHNSON STARTS FINAL TRIAL OF POTENTIAL SINGLE-DOSE COVID-19 VACCINE2020-09-24 21:20:32 看看新闻Knews综合关键词: JOHNSON&STARTSFINALTRIALOFPOTENTIALSINGLE-DOSECOVID-19VACCINEShanghai Live上海国际频道全部评论 请先登录后发表评论 暂无评论,快来发表你的评论吧...
Dan Barouch of the Beth Israel Deaconess Medical Center, who collaborated with Johnson & Johnson in the development of the vaccine. This September 2020 photo provided by Johnson & Johnson shows a single-dose COVID-19 vaccine being developed by the company. Cheryl Gerber/Courtesy of Johnson &...